Prot #219606: A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy versus Standard of Care in Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date6/18/246/18/27

Funding

  • PPD Investigator Services, LLC (Prot #219606 // Prot #219606)
  • GlaxoSmithKline LLC (Prot #219606 // Prot #219606)